Who
R. John Fletcher
Director
Company insider
Files Form 4 as: Director, ClearPoint Neuro; Director and Other, KORU Medical Systems; Director, OptiNose; Director, Vyant Bio; Director, Axcelis Technologies; Director, Spectranetics; Director, Marina Biotech; Director, Autoimmune.
In numbers
- Trades disclosed
- 204
- Buys
- 15
- Sells
- 6
- Bought
- $780K
- Sold
- $3.8M
- Companies
- 9
- Companies where not an officer
- 9
- First trade
- 7 Mar 2005
- Last trade
- 1 Oct 2026
- Last filed
- 2 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Oct 2026filed 2 Oct 2026 | CLPT ClearPoint NeuroMedical Devices | SEC FORM 4 Code A | $12K993 at $12.21 | filing |
| 1 Oct 2026filed 1 Oct 2026 | KRMD KORU Medical SystemsMedical Devices | SEC FORM 4 Code A | $22K7,679 at $2.93 | filing |
| 1 Jul 2026filed 6 Jul 2026 | CLPT ClearPoint NeuroMedical Devices | SEC FORM 4 Code A | $12K662 at $17.84 | filing |
| 1 Jul 2026filed 6 Jul 2026 | CLPT ClearPoint NeuroMedical Devices | SEC FORM 4 Code A | $12K662 at $17.84 | filing |
| 1 Jul 2026filed 1 Jul 2026 | KRMD KORU Medical SystemsMedical Devices | SEC FORM 4 Code A | $22K5,357 at $4.20 | filing |
| 1 Jul 2026filed 1 Jul 2026 | KRMD KORU Medical SystemsMedical Devices | SEC FORM 4 Code A | $22K5,357 at $4.20 | filing |
| 21 May 2026filed 26 May 2026 | CLPT ClearPoint Neurooption or derivative · Medical Devices | SEC FORM 4 Code A | —12,820 at $0.00 | filing |
| 21 May 2026filed 26 May 2026 | CLPT ClearPoint Neurooption or derivative · Medical Devices | SEC FORM 4 Code A | —12,820 at $0.00 | filing |
| 19 May 2026filed 21 May 2026 | CLPT ClearPoint NeuroMedical Devices | SEC FORM 4 Code M | —12,417 | filing |
| 19 May 2026filed 21 May 2026 | CLPT ClearPoint Neurooption or derivative · Medical Devices | SEC FORM 4 Code M | —12,417 | filing |
| 19 May 2026filed 21 May 2026 | CLPT ClearPoint Neurooption or derivative · Medical Devices | SEC FORM 4 Code M | —12,417 | filing |
| 19 May 2026filed 21 May 2026 | CLPT ClearPoint NeuroMedical Devices | SEC FORM 4 Code M | —12,417 | filing |
| 1 Apr 2026filed 2 Apr 2026 | CLPT ClearPoint NeuroMedical Devices | SEC FORM 4 Code A | $12K1,270 at $9.10 | filing |
| 1 Apr 2026filed 2 Apr 2026 | CLPT ClearPoint NeuroMedical Devices | SEC FORM 4 Code A | $12K1,270 at $9.10 | filing |
| 1 Apr 2026filed 1 Apr 2026 | KRMD KORU Medical SystemsMedical Devices | SEC FORM 4 Code A | $22K5,208 at $4.32 | filing |
| 1 Apr 2026filed 1 Apr 2026 | KRMD KORU Medical SystemsMedical Devices | SEC FORM 4 Code A | $22K5,208 at $4.32 | filing |
| 2 Jan 2026filed 5 Jan 2026 | CLPT ClearPoint NeuroMedical Devices | SEC FORM 4 Code A | $5,773422 at $13.68 | filing |
| 2 Jan 2026filed 5 Jan 2026 | CLPT ClearPoint NeuroMedical Devices | SEC FORM 4 Code A | $5,773422 at $13.68 | filing |
| 2 Jan 2026filed 2 Jan 2026 | KRMD KORU Medical SystemsMedical Devices | SEC FORM 4 Code A | $22K3,872 at $5.81 | filing |
| 2 Jan 2026filed 2 Jan 2026 | KRMD KORU Medical SystemsMedical Devices | SEC FORM 4 Code A | $22K3,872 at $5.81 | filing |
News
Axcelis Technologies To Start Construction Of Implantation Facility In South KoreaACLS · finanzen.ch · 20 Oct 2026
0 headlines in the last 90 days name R. John Fletcher; 1 article from the last 14 days about the 2 companies they traded most, at most three about any one of them.